这就是阿尔法试验小组最近成功的做法。
这项研究是阿尔法欧米茄试验的二次分析,是包括荷兰的32家医院的多中心研究。
This study was a secondary analysis of the Alpha Omega Trial, a multicenter study involving 32 hospitals in the Netherlands.
阿尔法支架是真正的第二代DES,结合了“顶级的”DES组件与已经过临床试验确认的安全性,有效性,以及卓越的药物释放控制能力。
Alpha Stent is the true 2nd generation DES that combines the "best-in-class" DES components and has demonstrated the outstanding safety, efficacy, and deliverability in a large scale clinical trial.
应用推荐